Where can I buy tucatinib? Summary of drug purchase channels at home and abroad

Tucatinib (Tucatinib) is a targeted therapy drug that has not yet been approved for marketing in the Chinese market, so domestic patients cannot purchase it directly through formal channels.

Currently, because tucatinib is not yet available in China, patients can only purchase it overseas. The original drug of tucatinib has been sold in the European market, and patients can purchase it through some international drug purchasing platforms or drug agents. The price of the European version of tucatinib is relatively expensive. A box of 150mg*84 tablets is priced at more than 40,000 yuan. Therefore, patients need to fully evaluate prices and purchasing channels to ensure that the source of drugs is reliable.

In addition to the original drug, tucatinib also has generic versions sold in overseas markets. For example, generic drugs produced by Lao pharmaceutical factories in the format of 150mg*60 tablets are relatively affordable, priced at more than 2,000 yuan. Since the ingredients of generic drugs are basically the same as those of original drugs and their prices are relatively reasonable, they have become the first choice for some patients. Generic drugs can be purchased through international drug purchasing agents or overseas pharmacies, but patients need to ensure the legality of the purchasing channel and the quality of the drugs.

At present, tucatinib has not been approved for marketing in China, so the drug cannot be purchased through regular domestic channels (such as pharmacies, hospitals, etc.). If patients need to use tucatinib, they must purchase the drug through legal overseas channels. For example, you can contact a professional drug purchasing company or an international drug platform to purchase. It should be noted that when purchasing drugs through these channels, prices and after-sales services may be different, and patients should choose reputable channels.

Since tucatinib has not yet been marketed in the country, it cannot be included in China's medical insurance system. Patients are required to bear the cost of medicines themselves, which is a financial burden for most patients. Relatively speaking, the price of generic drugs is more affordable and can effectively reduce the cost of treatment. However, due to the large price differences between different markets and channels, patients need to carefully compare prices from different sources when purchasing and choose options with high cost-effectiveness.

Reference materials:https://www.tukysa.com/